These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Shetty K; Timmins K; Brensinger C; Furth EE; Rattan S; Sun W; Rosen M; Soulen M; Shaked A; Reddy KR; Olthoff KM Liver Transpl; 2004 Jul; 10(7):911-8. PubMed ID: 15237377 [TBL] [Abstract][Full Text] [Related]
11. Sirolimus-based immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria. Zhou J; Wang Z; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY; Fan J Transplant Proc; 2008 Dec; 40(10):3548-53. PubMed ID: 19100435 [TBL] [Abstract][Full Text] [Related]
12. Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China. Zhou J; Fan J; Wu ZQ; Qiu SJ; Huang XW; Yu Y; Wang Z; Sun J; Xiao YS; He YF; Yang GH; Song K; Yuan Z; Wang YQ; Tang ZY Chin Med J (Engl); 2005 Apr; 118(8):654-9. PubMed ID: 15899120 [TBL] [Abstract][Full Text] [Related]
13. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis. Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001 [TBL] [Abstract][Full Text] [Related]
14. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression. Vivarelli M; Cucchetti A; Piscaglia F; La Barba G; Bolondi L; Cavallari A; Pinna AD Liver Transpl; 2005 May; 11(5):497-503. PubMed ID: 15838913 [TBL] [Abstract][Full Text] [Related]
15. Liver transplantation for hepatocellular carcinoma: results of a multicenter study with common priorization criteria. Santoyo J; Sanchez B; de la Mata M; Fernández-Aguilar JL; Lopez-Ciller P; Pascasio JM; Suarez MA; Gomez MA; Nogueras F; Muffak K; Cuende N; Alonso M Transplant Proc; 2009 Apr; 41(3):1009-11. PubMed ID: 19376412 [TBL] [Abstract][Full Text] [Related]
16. Impact of tumor characteristic on the outcome of liver transplantation in patients with hepatocellular carcinoma. Dudek K; Kornasiewicz O; Remiszewski P; Kobryń K; Ziarkiewicz-Wróblewska B; Górnicka B; Zieniewicz K; Krawczyk M Transplant Proc; 2009 Oct; 41(8):3135-7. PubMed ID: 19857695 [TBL] [Abstract][Full Text] [Related]
17. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study. Leung JY; Zhu AX; Gordon FD; Pratt DS; Mithoefer A; Garrigan K; Terella A; Hertl M; Cosimi AB; Chung RT Liver Transpl; 2004 Nov; 10(11):1343-54. PubMed ID: 15497158 [TBL] [Abstract][Full Text] [Related]
18. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma. Yang SH; Suh KS; Lee HW; Cho EH; Cho JY; Cho YB; Kim IH; Yi NJ; Lee KU Surgery; 2007 May; 141(5):598-609. PubMed ID: 17462459 [TBL] [Abstract][Full Text] [Related]
19. Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study. Figueras J; Ibañez L; Ramos E; Jaurrieta E; Ortiz-de-Urbina J; Pardo F; Mir J; Loinaz C; Herrera L; López-Cillero P; Santoyo J Liver Transpl; 2001 Oct; 7(10):877-83. PubMed ID: 11679986 [TBL] [Abstract][Full Text] [Related]
20. Predictive factors of outcome after liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Merli M; Nicolini G; Gentili F; Novelli G; Iappelli M; Casciaro G; Di Tondo U; Pecorella I; Marasco A; Onetti Muda A; Nudo F; Mennini G; Ginanni Corradini S; Riggio O; Berloco P; Attili AF; Rossi M Transplant Proc; 2005; 37(6):2535-40. PubMed ID: 16182736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]